JP2009510025A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009510025A5 JP2009510025A5 JP2008532788A JP2008532788A JP2009510025A5 JP 2009510025 A5 JP2009510025 A5 JP 2009510025A5 JP 2008532788 A JP2008532788 A JP 2008532788A JP 2008532788 A JP2008532788 A JP 2008532788A JP 2009510025 A5 JP2009510025 A5 JP 2009510025A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- attachment site
- amino acid
- composition
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72110605P | 2005-09-28 | 2005-09-28 | |
| US60/721,106 | 2005-09-28 | ||
| PCT/EP2006/066866 WO2007039552A1 (en) | 2005-09-28 | 2006-09-28 | Interleukin-1 conjugates and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009510025A JP2009510025A (ja) | 2009-03-12 |
| JP2009510025A5 true JP2009510025A5 (enExample) | 2009-11-05 |
| JP5312028B2 JP5312028B2 (ja) | 2013-10-09 |
Family
ID=37497973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008532788A Expired - Fee Related JP5312028B2 (ja) | 2005-09-28 | 2006-09-28 | インターロイキン−１コンジュゲート及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20110027220A1 (enExample) |
| EP (2) | EP2431468A1 (enExample) |
| JP (1) | JP5312028B2 (enExample) |
| KR (1) | KR20080047564A (enExample) |
| CN (2) | CN101267834B (enExample) |
| AU (1) | AU2006298767B2 (enExample) |
| BR (1) | BRPI0616446A2 (enExample) |
| CA (1) | CA2623287A1 (enExample) |
| IL (1) | IL189245A0 (enExample) |
| NZ (1) | NZ566971A (enExample) |
| RU (1) | RU2441067C2 (enExample) |
| WO (1) | WO2007039552A1 (enExample) |
| ZA (1) | ZA200802225B (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1450856B1 (en) | 2001-09-14 | 2009-11-11 | Cytos Biotechnology AG | Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use |
| DK1915620T3 (da) | 2005-08-02 | 2010-10-04 | Xbiotech Inc | Diagnose, behandling og prævention af vaskulære sygdomme ved hjælp af IL-1alpha-autoantistoffer |
| EP2021033B1 (en) | 2006-05-15 | 2012-03-28 | XBiotech, Inc | Il-1-alpha for use in a method of treatment of atherosclerotic plaques. |
| US20110008282A1 (en) * | 2006-05-15 | 2011-01-13 | Xbiotech, Inc. | IL-1alpha immunization induces autoantibodies protective against atherosclerosis |
| SI2032592T1 (sl) | 2006-06-12 | 2013-10-30 | Cytos Biotechnology Ag | Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov |
| WO2008071774A1 (en) * | 2006-12-14 | 2008-06-19 | Cytos Biotechnology Ag | Purification process for coat protein of rna bacteriophages |
| KR20100084623A (ko) * | 2007-09-25 | 2010-07-27 | 인터벳 인터내셔널 비.브이. | 골관절염 치료용 백신 |
| NZ587670A (en) * | 2008-03-05 | 2012-11-30 | Cytos Biotechnology Ag | Use of interleukin-1 conjugates in the treatment of diabetes |
| HUE029003T2 (en) | 2008-05-30 | 2017-01-30 | Xbiotech Inc | IL-1 alpha antibodies |
| JP5976319B2 (ja) | 2008-09-12 | 2016-08-23 | エックスバイオテク, インコーポレイテッドXbiotech, Inc. | 病原性単球の標的化 |
| PL222496B1 (pl) * | 2009-04-10 | 2016-08-31 | Inst Biochemii I Biofizyki Pan | Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania oraz kompozycja farmaceutyczna zawierająca wektorową cząsteczkę wirusopodobną |
| US8993715B2 (en) * | 2009-07-06 | 2015-03-31 | Canon Kabushiki Kaisha | Labeled protein and method for obtaining the same |
| CN102497885A (zh) * | 2009-09-10 | 2012-06-13 | 赛托斯生物技术公司 | 白介素-1β突变蛋白偶联物在糖尿病治疗中的用途 |
| CN102946904A (zh) | 2010-06-18 | 2013-02-27 | 埃克斯生物科技公司 | 关节炎治疗 |
| PH12013500316A1 (en) | 2010-08-23 | 2016-09-02 | Janssen Biotech Inc | Treatment for neoplastic diseases |
| US9724409B2 (en) | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
| PT2750709T (pt) | 2011-09-23 | 2018-11-22 | Xbiotech Inc | Tratamento da caquexia |
| SG11201404991YA (en) | 2012-02-23 | 2014-09-26 | Stage Cell Therapeutics Gmbh | Chromatographic isolation of cells and other complex biological materials |
| US9545441B2 (en) | 2012-09-18 | 2017-01-17 | Xbiotech, Inc. | Treatment of diabetes |
| GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
| US11168306B2 (en) | 2014-02-25 | 2021-11-09 | The Regents Of The University Of California | Phage wrapping |
| AU2016207099C1 (en) * | 2015-01-15 | 2021-02-04 | University Of Copenhagen | Virus-like particle with efficient epitope display |
| MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
| RU2761555C2 (ru) * | 2015-10-22 | 2021-12-09 | Джуно Терапьютикс Гмбх | Способы, наборы, средства и устройства для трансдукции |
| KR102908806B1 (ko) | 2015-10-22 | 2026-01-07 | 주노 테라퓨틱스 게엠베하 | 세포의 배양 방법 및 이를 위한 키트와 장치 |
| WO2017071713A1 (en) | 2015-10-30 | 2017-05-04 | University Of Copenhagen | Virus like particle with efficient epitope display |
| JP7145162B2 (ja) | 2017-02-16 | 2022-09-30 | ヤンセン バイオテク，インコーポレイテッド | 化膿性汗腺炎の処置 |
| AU2018260380B2 (en) | 2017-04-27 | 2025-02-13 | Juno Therapeutics Gmbh | Oligomeric particle reagents and methods of use thereof |
| WO2019160866A2 (en) | 2018-02-13 | 2019-08-22 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
| BR112020020479A2 (pt) | 2018-04-09 | 2021-01-12 | Checkmate Pharmaceuticals | Empacotamento de oligonucleotídeos em partículas similares a vírus |
| BR112021002390A2 (pt) | 2018-08-09 | 2021-05-11 | Juno Therapeutics Inc | processos para gerar células modificadas e suas composições |
| WO2020089343A1 (en) | 2018-10-31 | 2020-05-07 | Juno Therapeutics Gmbh | Methods for selection and stimulation of cells and apparatus for same |
| EP3845556A1 (fr) * | 2019-12-31 | 2021-07-07 | Peptinov SAS | Conjugue immunogene destine a induire une reponse immunitaire dirigee contre l interleukine-6 |
| BR112022022089A2 (pt) * | 2020-05-22 | 2022-12-13 | R Pharm Overseas Inc | Composição de proteína heterodimérica, composição terapêutica que compreende a mesma e uso da dita composição para tratar uma doença associada à modulação de il-1ss |
| CA3095740A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleukin alpha (il-1a) |
| CA3095679A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleuken 1 alpha (il-1a) |
| CA3095676A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleukin 1 alpha (il-1a) |
| CA3095675A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleukin 1 alpha (il-1a) |
| JP2024527571A (ja) * | 2021-07-08 | 2024-07-25 | オリオンズ バイオサイエンス インコーポレイテッド | インターロイキン－１アルファキメラタンパク質 |
| WO2025186318A2 (en) | 2024-03-06 | 2025-09-12 | Elanco Us Inc. | Veterinary compositions of modified virus-like particles of cmv and feline il-1beta mutein antigens |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374426A (en) | 1986-09-03 | 1994-12-20 | University Of Saskatchewan | Rotavirus nucleocapsid protein VP6 in vaccine compositions |
| ATE165114T1 (de) | 1989-02-27 | 1998-05-15 | New England Medical Center Inc | Il-1, dessen biologische aktivität inhibiert ist |
| EP0563091A1 (en) | 1990-12-20 | 1993-10-06 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccines based on hepatitis b surface antigen |
| GB9101550D0 (en) | 1991-01-24 | 1991-03-06 | Mastico Robert A | Antigen-presenting chimaeric protein |
| FR2677654B1 (fr) | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. |
| GB9114003D0 (en) | 1991-06-28 | 1991-08-14 | Mastico Robert A | Chimaeric protein |
| AU700819B2 (en) * | 1994-10-07 | 1999-01-14 | Chugai Seiyaku Kabushiki Kaisha | Rheumatoid arthritis remedy containing IL-6 antagonist as effective component |
| CN1185811A (zh) | 1995-03-31 | 1998-06-24 | H·沃尔夫 | 依赖于逆转录病毒样颗粒的抗原呈递系统 |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| WO2000023955A1 (en) * | 1998-10-21 | 2000-04-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Virus-like particles for the induction of autoantibodies |
| MXPA01005389A (es) | 1998-11-30 | 2003-03-27 | Cytos Biotechnology Ag | Presentacion molecular ordenada de antigenos, metodos de preparacion y uso. |
| JP2003515569A (ja) | 1999-12-03 | 2003-05-07 | セルテック アール アンド ディ リミテッド | ワクチンアジュバントとして有用なインターロイキン−１ムテイン |
| DE10004232A1 (de) | 2000-02-01 | 2001-08-02 | Megamat Gmbh Buero Und Lagerte | Antriebseinrichtung für eine Lagervorrichtung |
| AU2001233212A1 (en) * | 2000-02-02 | 2001-08-14 | Schering Corporation | Mammalian cytokines; receptors; related reagents and methods |
| EP1278542A2 (en) | 2000-05-05 | 2003-01-29 | Cytos Biotechnology AG | Molecular antigen arrays and vaccines |
| WO2003031466A2 (en) * | 2001-10-05 | 2003-04-17 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
| EP1450856B1 (en) | 2001-09-14 | 2009-11-11 | Cytos Biotechnology AG | Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use |
| JP4533626B2 (ja) * | 2001-11-07 | 2010-09-01 | サイトス バイオテクノロジー アーゲー | アレルギー性好酸球性疾患を治療するための抗原アレイ |
| MXPA04003900A (es) * | 2001-11-07 | 2004-07-08 | Cytos Biotechnology Ag | Disposiciones de antigenos para el tratamiento de enfermedades oseas. |
| DE60230656D1 (de) * | 2001-11-07 | 2009-02-12 | Cytos Biotechnology Ag | Antigenraster welche il-5, il-13 oder eotaxin präshilen erkrankungen |
| FR2838444B1 (fr) | 2002-04-10 | 2016-01-01 | Neovacs | Nouveaux peptides et leur application en therapeutique |
| AU2003246690B2 (en) * | 2002-07-17 | 2010-03-11 | Cytos Biotechnology Ag | Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| NZ537003A (en) * | 2002-07-18 | 2008-03-28 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| RU2325202C2 (ru) * | 2002-07-19 | 2008-05-27 | Цитос Байотекнолоджи Аг | Конъюгаты грелин-носитель |
| EP1706152A2 (en) * | 2004-01-20 | 2006-10-04 | Cytos Biotechnology AG | Particle-induced ghrelin immune response |
| NZ554387A (en) | 2004-09-21 | 2009-09-25 | Cytos Biotechnology Ag | Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide |
| EP1812051A2 (en) | 2004-10-05 | 2007-08-01 | Cytos Biotechnology AG | Vlp-antigen conjugates and their uses as vaccines |
-
2006
- 2006-09-28 BR BRPI0616446-3A patent/BRPI0616446A2/pt not_active IP Right Cessation
- 2006-09-28 NZ NZ566971A patent/NZ566971A/en not_active IP Right Cessation
- 2006-09-28 US US11/992,731 patent/US20110027220A1/en not_active Abandoned
- 2006-09-28 EP EP11175319A patent/EP2431468A1/en not_active Withdrawn
- 2006-09-28 JP JP2008532788A patent/JP5312028B2/ja not_active Expired - Fee Related
- 2006-09-28 AU AU2006298767A patent/AU2006298767B2/en not_active Ceased
- 2006-09-28 RU RU2008116323/10A patent/RU2441067C2/ru not_active IP Right Cessation
- 2006-09-28 CN CN2006800343698A patent/CN101267834B/zh not_active Expired - Fee Related
- 2006-09-28 KR KR1020087006840A patent/KR20080047564A/ko not_active Withdrawn
- 2006-09-28 CA CA002623287A patent/CA2623287A1/en not_active Abandoned
- 2006-09-28 CN CN2013101441929A patent/CN103230590A/zh active Pending
- 2006-09-28 EP EP06793894A patent/EP1931383A1/en not_active Withdrawn
- 2006-09-28 ZA ZA200802225A patent/ZA200802225B/xx unknown
- 2006-09-28 WO PCT/EP2006/066866 patent/WO2007039552A1/en not_active Ceased
-
2007
- 2007-03-29 US US12/443,344 patent/US8449874B2/en not_active Expired - Fee Related
-
2008
- 2008-02-04 IL IL189245A patent/IL189245A0/en unknown
-
2012
- 2012-08-01 US US13/564,576 patent/US20130230484A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7084965B2 (ja) | 特異的結合ポリペプチドおよびその使用 | |
| US8449874B2 (en) | Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases | |
| JP2008535800A5 (enExample) | ||
| JP2007521807A5 (enExample) | ||
| JP2008543278A (ja) | フィブロネクチンｅｄ−ｂに対する抗体ｌ１９とインターロイキン１２との融合タンパク質 | |
| US20090123414A1 (en) | Il-15 Antigen Arrays And Uses Thereof | |
| JP2006519781A5 (enExample) | ||
| JP2006504653A5 (enExample) | ||
| RU2007138265A (ru) | Белки, слитые с кошачьим аллергеном, и их применение | |
| JP2004531546A (ja) | 敗血症の治療または予防のためのｉｌ−１８阻害剤の使用 | |
| JP2008521426A5 (enExample) | ||
| KR20050044316A (ko) | 호산구성 알레르기 질환 치료용의 ｉｌ-5, ｉｌ-13 또는에오탁신을 제시하는 항원 어레이 | |
| CA2664418A1 (en) | Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases | |
| RU2010140443A (ru) | Применение коньюгатов интерлейкина-1 в лечении диабета | |
| JP2005530723A (ja) | 新規ペプチド及び治療を目的とするその利用 | |
| ITFI20090006A1 (it) | Processo per la produzione di proteine di fusione polivalenti e polispecifiche utilizzando come struttura portante l'uteroglobina e prodotti cosi' ottenuti. | |
| JPH08511542A (ja) | コイル状−コイルステムループ鋳型 | |
| JP4533626B2 (ja) | アレルギー性好酸球性疾患を治療するための抗原アレイ | |
| JP2005514347A5 (enExample) | ||
| JP4658475B2 (ja) | 骨疾患治療用の抗原アレイ | |
| CN118620057A (zh) | Il-1r1胞外区多肽突变体及其用途 | |
| KR20220157366A (ko) | 인터루킨-6에 대한 면역 반응을 유도시키기 위한 면역원성 접합체 | |
| AU2013202547A1 (en) | Interleukin-1 conjugates and uses thereof | |
| HK1219902B (en) | Biosynthetic proline/alanine random coil polypeptides and their uses | |
| TH91918A (th) | แอนติบอดี c-kit ที่ทำให้เป็นแบบของมนุษย์ |